Yesterday, President Trump announced the 17th agreement with a major pharmaceutical manufacturer, Regeneron, to deliver the lowest prescription drug prices for the American people.
Regeneron will also invest $27 billion into U.S. research, development, and manufacturing – bringing the total amount of pharmaceutical investments under President Trump to $448 billion in just 15 months.
President Trump has partnered with 17 major pharmaceutical companies to lower costs for Americans:
President
Trump is putting America First: bringing billions of dollars of investments
back to our country, lowering prices for prescription drugs, and strengthening
healthcare for the American people.
